Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series-Reference-Cited by-同舟云学术

Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series

Published:2018-03 Issue: Volume:103 Page:25-28
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Yokoyama Yoko,Kamikozuru Koji,Watanabe Kenji,Nakamura Shiro

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference16 articles.

1. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

2. Review article: loss of response to anti-TNF treatments in Crohn’s disease;Ben-Horin;Aliment. Pharmacol. Ther.,2011

3. Doubling the infliximab dose versus halving the infusion intervals in Crohn’s disease patients with loss of response;Katz;Inflamm. Bowel Dis.,2012

4. Comparison of efficacy, pharmacokinetics, and immunogenicity between infliximab mono- versus combination therapy in ulcerative colitis;Hayes;J. Gastroenterol. Hepatol.,2014

5. Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed;Gisbert;Aliment. Pharmacol. Ther.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study;Gastroenterología y Hepatología;2024-08

2. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología;2024-08

3. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study;Gastroenterología y Hepatología (English Edition);2024-08

4. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología (English Edition);2024-08

5. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study;Gastroenterología y Hepatología;2024-05